How does legal voluntary assisted dying impact conventional suicides among cancer patients?

Publicly released:
International
Photo by National Cancer Institute on Unsplash
Photo by National Cancer Institute on Unsplash

***This media release contains information some readers may find distressing as it refers to data about mental health, suicide and self-harm. If you or anyone you know needs help, support is available now. Call Lifeline on 131 114 or Beyond Blue on 1300 22 4636. ***

The amount of cancer patients choosing assisted dying in Switzerland is increasing over time while the amount of cancer-related conventional suicides is trending downwards, according to international researchers. Assisted dying has been legal in Switzerland since the 1940s, so researchers used their data to look at cancer-related suicides from 1999-2018. They say cancer patients made up 41% of those who chose assisted dying - 3580 people overall. There were 832 cancer-related conventional suicides over that time, they say, which made up 3.8% of the conventional suicides in the country.

Media release

From: Wiley

Does access to assisted suicide affect trends of conventional suicide among patients with cancer?

An analysis published in Cancer Medicine reveals the trends of self-initiated deaths—including assisted suicide (AS) and conventional suicide (CS)—in Switzerland over a 20-year period, focusing on people who suffered from cancer. Although supporters of assisted dying state that access to AS should lead to a reduction in violent CS, the study’s findings do not confirm this assumption. The situations and motivations for cancer-associated CS seem to be clearly different from those for cancer-related AS.

In Switzerland, assisting in a suicide is not punishable as long as it does not serve selfish motives. In this analysis of data from 1999–2018, investigators found that cancer was the most often listed principal disease for AS: 3,580 people with cancer died by AS, representing 41.0% of AS cases. Cancer was listed in only a small minority of CS cases (832 people, representing 3.8% of CS cases). 

There was approximately a doubling of AS cases among patients with cancer every 5 years. Also, the percentage of cancer-associated AS in relationship with all cancer-associated deaths increased over time to 2.3% in 2014–2018. The numbers of cancer-associated CS showed a downward trend in 1999–2003 and were stable through 2009–2018.

“Obviously, the situations and motivations for cancer-associated CS seem to be clearly different from those for cancer-related AS,” said corresponding author Uwe Güth, MD, of the University of Basel.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Wiley, Web page The URL will go live after the embargo ends
Journal/
conference:
Cancer Medicine
Research:Paper
Organisation/s: University of Basel, Switzerland
Funder: There was no financial support for our research
Media Contact/s
Contact details are only visible to registered journalists.